Cyklokapron
Hyperfibrinolysis, Hemorrhage, Angioedemas, Hereditary + 3 more
Treatment
14 Active Studies for Cyklokapron
Treatment for
Hyperfibrinolysis
What is Cyklokapron
Tranexamic acid
The Generic name of this drug
Treatment Summary
Tranexamic acid is a medication that helps to reduce bleeding. It is a synthetic form of lysine, and is more effective than other similar drugs. It was first patented in 1957 and approved for use in the United States in 1986.
Cyklokapron
is the brand name
Cyklokapron Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Cyklokapron
Tranexamic acid
1986
57
Effectiveness
How Cyklokapron Affects Patients
Tranexamic acid is a medication used to reduce bleeding. It works by stopping the breakdown of blood clots, which helps to stop bleeding. It is used to treat hereditary angioedema, a condition that causes swelling. In some cases, tranexamic acid can cause convulsions or increased excitability in patients. Therefore, those with a history of seizures should have their EEG monitored when taking this drug.
How Cyklokapron works in the body
Tranexamic acid works by stopping the breakdown of blood clots. It does this by attaching to the same sites on blood clots that would normally cause them to dissolve. By occupying these sites, it prevents the clot from breaking down and stops bleeding.
When to interrupt dosage
The advised dosage of Cyklokapron is contingent upon the diagnosed condition, including Tooth Extractions, Angioedemas, Hereditary and Hemophilia. The amount also deviates as per the mode of delivery (e.g. Cream - Topical or Injection, solution - Intravenous) outlined in the table beneath.
Condition
Dosage
Administration
Hyperfibrinolysis
100.0 mg/mL, , 650.0 mg, 0.005 mg/mL, 500.0 mg, 2.0 mg/mL, 5.0 mg/mL, 0.1 mg/mL, 10.0 mg/mL, 500.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Topical, Cream, Cream - Topical, Solution, Solution - Intravenous, Injection, Injection - Intravenous, Liquid, Liquid - Topical
Hemorrhage
100.0 mg/mL, , 650.0 mg, 0.005 mg/mL, 500.0 mg, 2.0 mg/mL, 5.0 mg/mL, 0.1 mg/mL, 10.0 mg/mL, 500.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Topical, Cream, Cream - Topical, Solution, Solution - Intravenous, Injection, Injection - Intravenous, Liquid, Liquid - Topical
Angioedemas, Hereditary
100.0 mg/mL, , 650.0 mg, 0.005 mg/mL, 500.0 mg, 2.0 mg/mL, 5.0 mg/mL, 0.1 mg/mL, 10.0 mg/mL, 500.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Topical, Cream, Cream - Topical, Solution, Solution - Intravenous, Injection, Injection - Intravenous, Liquid, Liquid - Topical
Hemophilia A
100.0 mg/mL, , 650.0 mg, 0.005 mg/mL, 500.0 mg, 2.0 mg/mL, 5.0 mg/mL, 0.1 mg/mL, 10.0 mg/mL, 500.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Topical, Cream, Cream - Topical, Solution, Solution - Intravenous, Injection, Injection - Intravenous, Liquid, Liquid - Topical
Menorrhagia
100.0 mg/mL, , 650.0 mg, 0.005 mg/mL, 500.0 mg, 2.0 mg/mL, 5.0 mg/mL, 0.1 mg/mL, 10.0 mg/mL, 500.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Topical, Cream, Cream - Topical, Solution, Solution - Intravenous, Injection, Injection - Intravenous, Liquid, Liquid - Topical
Tooth Extractions
100.0 mg/mL, , 650.0 mg, 0.005 mg/mL, 500.0 mg, 2.0 mg/mL, 5.0 mg/mL, 0.1 mg/mL, 10.0 mg/mL, 500.0 mg/mL
, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, Tablet - Oral, Oral, Tablet, film coated, Tablet, film coated - Oral, Topical, Cream, Cream - Topical, Solution, Solution - Intravenous, Injection, Injection - Intravenous, Liquid, Liquid - Topical
Warnings
Cyklokapron Contraindications
Condition
Risk Level
Notes
NF1 gene
Do Not Combine
Thrombosis
Do Not Combine
Thromboembolism
Do Not Combine
Pulse Frequency
Do Not Combine
Subarachnoid Hemorrhage
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Tranexamic Acid may interact with Pulse Frequency
There are 20 known major drug interactions with Cyklokapron.
Common Cyklokapron Drug Interactions
Drug Name
Risk Level
Description
Albutrepenonacog alfa
Major
Tranexamic acid may increase the thrombogenic activities of Albutrepenonacog alfa.
Aminocaproic acid
Major
Tranexamic acid may increase the thrombogenic activities of Aminocaproic acid.
Aminomethylbenzoic acid
Major
Tranexamic acid may increase the thrombogenic activities of Aminomethylbenzoic acid.
Andexanet alfa
Major
Tranexamic acid may increase the thrombogenic activities of Andexanet alfa.
Anti-inhibitor coagulant complex
Major
Tranexamic acid may increase the thrombogenic activities of Anti-inhibitor coagulant complex.
Cyklokapron Toxicity & Overdose Risk
Too much tranexamic acid can cause severe stomach issues, low blood pressure, blood clots, vision problems, seizures, changes in mental state, and skin rashes.
Cyklokapron Novel Uses: Which Conditions Have a Clinical Trial Featuring Cyklokapron?
34 active trials are in progress to assess the potential of Cyklokapron in managing Hemophilia, Hemorrhage and Hereditary Angioedemas.
Condition
Clinical Trials
Trial Phases
Hemorrhage
0 Actively Recruiting
Tooth Extractions
3 Actively Recruiting
Not Applicable, Early Phase 1
Hyperfibrinolysis
0 Actively Recruiting
Angioedemas, Hereditary
12 Actively Recruiting
Phase 3, Phase 1, Phase 2, Phase 4
Menorrhagia
0 Actively Recruiting
Hemophilia A
0 Actively Recruiting
Cyklokapron Reviews: What are patients saying about Cyklokapron?
5
Patient Review
10/4/2019
Cyklokapron for Abnormally Long or Heavy Periods
5
Patient Review
7/9/2022
Cyklokapron for Abnormally Long or Heavy Periods
5
Patient Review
5/18/2022
Cyklokapron for Abnormally Long or Heavy Periods
5
Patient Review
9/27/2021
Cyklokapron for Abnormally Long or Heavy Periods
5
Patient Review
5/18/2022
Cyklokapron for Abnormally Long or Heavy Periods
5
Patient Review
7/9/2022
Cyklokapron for Abnormally Long or Heavy Periods
5
Patient Review
10/4/2019
Cyklokapron for Abnormally Long or Heavy Periods
5
Patient Review
9/27/2021
Cyklokapron for Abnormally Long or Heavy Periods
4.7
Patient Review
7/17/2022
Cyklokapron for Abnormally Long or Heavy Periods
4.7
Patient Review
7/17/2022
Cyklokapron for Abnormally Long or Heavy Periods
4.3
Patient Review
12/7/2020
Cyklokapron for Abnormally Long or Heavy Periods
4.3
Patient Review
12/7/2020
Cyklokapron for Abnormally Long or Heavy Periods
4
Patient Review
5/21/2022
Cyklokapron for Abnormally Long or Heavy Periods
4
Patient Review
1/20/2022
Cyklokapron for Abnormally Long or Heavy Periods
4
Patient Review
1/20/2022
Cyklokapron for Abnormally Long or Heavy Periods
4
Patient Review
5/21/2022
Cyklokapron for Abnormally Long or Heavy Periods
2.3
Patient Review
6/6/2022
Cyklokapron for Abnormally Long or Heavy Periods
2.3
Patient Review
6/6/2022
Cyklokapron for Abnormally Long or Heavy Periods
1.7
Patient Review
4/23/2022
Cyklokapron for Abnormally Long or Heavy Periods
1.7
Patient Review
4/23/2022
Cyklokapron for Abnormally Long or Heavy Periods
Patient Q&A Section about cyklokapron
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What type of medication is CYKLOKAPRON?
"Cyklokapron is a man-made form of lysine, an amino acid, used to prevent bleeding in people with hemophilia who need dental procedures. Cyklokapron is typically given just before the dental procedure and daily for up to eight days afterward."
Answered by AI
How long does it take for CYKLOKAPRON to work?
"The medicine will not have its full effect for up to 24 hours. Tranexamic acid is typically only used for a short time to treat bleeding. For heavy periods, it is usually taken for four days, or for seven days to treat other types of bleeding that does not stop on its own."
Answered by AI
Is CYKLOKAPRON a blood thinner?
"Tranexamic acid reduces the amount of blood loss and is used to control unwanted bleeding. Side-effects are usually minor and rare."
Answered by AI
What is CYKLOKAPRON used for?
"This medication is used to prevent and reduce bleeding from a tooth extraction in people with hemophilia, a bleeding disorder."
Answered by AI